Walters Group Buys $15.2M in Zentalis Pharmaceuticals (ZNTL)
A Form 4 filing with the Securities and Exchange Commission shows that Walters Group, a 10%+ owner of Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL), purchased 4,335,000 shares of the company’s common stock on August 14, 2026. The transaction was an open-market purchase, meaning the insider used its own capital to acquire the shares rather than receiving … Read more